RT @nataliexdean: Out in @TheLancet, results from the Oxford/AZN trials, including more detail on the low dose results. Notably, the low do…
RT @pawinpawin: ยังไม่ทันขาดคำ วัคซีนของทาง Oxford ที่เราซื้อผลก็ออกมาแล้วเหมือนกันครับ
RT @vass_vassiliou The Oxford @AstraZeneca #vaccine study out @lancet DEFINITELY WORTH A READ! The data are out,the jury yours @mmamas1973 @DrMarthaGulati @purviparwani @florian_krammer @hvanspall @ErinMichos @iamritu @AnastasiaSMihai @VietHeartPA @Abrah
RT @pawinpawin: ยังไม่ทันขาดคำ วัคซีนของทาง Oxford ที่เราซื้อผลก็ออกมาแล้วเหมือนกันครับ
RT @Fraslin: Innocuité et efficacité du vaccin ChAdOx1 nCoV-19 (AZD1222) Oxford/AstraZeneca contre le SRAS-CoV-2: une analyse intermédiaire…
RT @GiacomoGorini: Ecco qua, i dati di efficacia fase III del vaccino Oxford-AZ pubblicati proprio adesso sul Lancet! Ora tutta la comunità…
RT @ajpollard1: Dedicated to our friends and colleagues who have lost their lives during the pandemic https://t.co/Y70OyvbwOK
RT @vass_vassiliou: The Oxford @AstraZeneca vaccine study out @lancet! https://t.co/6xVBEKRqNT DEFINITELY WORTH A READ! The data are out,…
RT @TahtakusIar: Aşı çalışmalarının ara sonuçları peş peşe gelmeye başladı. Oxford-AstraZeneca'nın devam eden Faz 3 çalışmasının ara sonuc…
RT @ajpollard1: Dedicated to our friends and colleagues who have lost their lives during the pandemic https://t.co/Y70OyvbwOK
RT @TahtakusIar: Aşı çalışmalarının ara sonuçları peş peşe gelmeye başladı. Oxford-AstraZeneca'nın devam eden Faz 3 çalışmasının ara sonuc…
OXFORD/AZ VACCINE. 2 standard doses: vaccine efficacy 62% (27/4440 in vaccine vs 71/4455 in control). From 21 days after 1st dose, 10 cases hospitalised #COVID ALL in control arm. 74,341 person-months safety (adverse events 84 vaccine, 91 control). https:/
Congratulations to @ajpollard1 and team who did an incredible job on the development and study of the Oxford #Covid_19 vaccine. Thank you for your dedication and hard work that made this possible. @ESPIDsociety https://t.co/w0oJ2mqH3K
Pierwsze pełne dane - AstraZeneca x skuteczność 62% x częściowo《 szansa na zakażenie x zamieszanie z dawkami = błędna metoda mianowania na początku. x wyższa skuteczność przy niższej dawce. Zbyt mała grupa czy utrata skuteczności przez Abs anty ADV? http
RT @drilkerbelek: Oxford-AstraZeneca aşısının faz-3 sonuçları Lancet'te yayımladı. Bu faz-3'ü yayımlanan ilk araştırma oluyor. Düşük doz il…
RT @prieto_alhambra: Informe complet i 'peer reviewed' d'eficàcia i seguretat de l'anomenada "vacuna d'Oxford" (ChadOx1), ja disponibles a…
RT @vass_vassiliou: The Oxford @AstraZeneca vaccine study out @lancet! https://t.co/6xVBEKRqNT DEFINITELY WORTH A READ! The data are out,…
RT @TheLancet: NEW—First full results from interim analysis confirm that the Oxford #COVID19 vaccine is safe and efficacious against sympto…
RT @TahtakusIar: Aşı çalışmalarının ara sonuçları peş peşe gelmeye başladı. Oxford-AstraZeneca'nın devam eden Faz 3 çalışmasının ara sonuc…
Aşı çalışmalarının ara sonuçları peş peşe gelmeye başladı. Oxford-AstraZeneca'nın devam eden Faz 3 çalışmasının ara sonucu Lancet'te yayınlandı. 23 848 gönüllü üzerinde 2 doz uygulanan aşı, %90 etkin bulundu. https://t.co/0czDfRWOFE
Premiers résultats du vaccin d'AstraZeneca dans le Lancet https://t.co/CerNjMPKYC
RT @prieto_alhambra: Informe complet i 'peer reviewed' d'eficàcia i seguretat de l'anomenada "vacuna d'Oxford" (ChadOx1), ja disponibles a…
RT @TheLancet: NEW—First full results from interim analysis confirm that the Oxford #COVID19 vaccine is safe and efficacious against sympto…
Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK - ScienceDirect One step closer to another avenue to protection https://t.co/aa2
RT @TheLancet: NEW—First full results from interim analysis confirm that the Oxford #COVID19 vaccine is safe and efficacious against sympto…
RT @pawinpawin: ยังไม่ทันขาดคำ วัคซีนของทาง Oxford ที่เราซื้อผลก็ออกมาแล้วเหมือนกันครับ
RT @EricTopol: Just out @TheLancet: @AstraZeneca @UniofOxford vaccine interim trial results —Higher efficacy w/ low dose looks real, not li…
RT @TheLancet: NEW—First full results from interim analysis confirm that the Oxford #COVID19 vaccine is safe and efficacious against sympto…
RT @prieto_alhambra: Informe complet i 'peer reviewed' d'eficàcia i seguretat de l'anomenada "vacuna d'Oxford" (ChadOx1), ja disponibles a…
RT @JLTrejo2: Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised contr…
RT @ajpollard1: Dedicated to our friends and colleagues who have lost their lives during the pandemic https://t.co/Y70OyvbwOK
RT @Martha_Vickers: ✨👇
RT @EricTopol: Just out @TheLancet: @AstraZeneca @UniofOxford vaccine interim trial results —Higher efficacy w/ low dose looks real, not li…
RT @EricTopol: Just out @TheLancet: @AstraZeneca @UniofOxford vaccine interim trial results —Higher efficacy w/ low dose looks real, not li…
✨👇
RT @bengibaser: 📌Lancet dergisinde Oxford aşısı Faz III çalışmalarının ilk sonuçları yayınlandı. Aşının ilk dozu dusuk, ikinci dozu yüksek…
RT @pawinpawin: ยังไม่ทันขาดคำ วัคซีนของทาง Oxford ที่เราซื้อผลก็ออกมาแล้วเหมือนกันครับ
RT @prieto_alhambra: Informe complet i 'peer reviewed' d'eficàcia i seguretat de l'anomenada "vacuna d'Oxford" (ChadOx1), ja disponibles a…
RT @CaKizil: Oxford aşısının analizi @TheLancet dergisinde yayımlandı. Çalışma, aşının güvenli ve etkili olduğunu belirtiyor. Oldukça güzel…
RT @TheLancetInfDis: Just published @TheLancet: Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim…
Oxford-AstraZeneca aşısının faz-3 sonuçları Lancet'te yayımladı. Bu faz-3'ü yayımlanan ilk araştırma oluyor. Düşük doz ilk aşıdan sonra yapılan standart dozdaki ikinci aşıda %90 koruyuculuk bildiriliyor. Yan etkileri sınırlı. https://t.co/qINszwnwBA
RT @cmgorriaran: Para quienes quieren más información: The Lancet, una de las primeras revistas de medicina independiente del mundo (una re…
👇✨
RT @centinel5051: Por fin se han publicado los resultados de los ensayos de la vacuna de Oxford - Astra Zeneca contra el coronavirus. https…
RT @bengibaser: 📌Lancet dergisinde Oxford aşısı Faz III çalışmalarının ilk sonuçları yayınlandı. Aşının ilk dozu dusuk, ikinci dozu yüksek…
RT @TheLancet: NEW—First full results from interim analysis confirm that the Oxford #COVID19 vaccine is safe and efficacious against sympto…
RT @gary_lyman: Total of 5 neoplasms including benign ones in the entire study. Absolutely no useful information about role of vaccine in p…
RT @pawinpawin: ยังไม่ทันขาดคำ วัคซีนของทาง Oxford ที่เราซื้อผลก็ออกมาแล้วเหมือนกันครับ
RT @EricTopol: Just out @TheLancet: @AstraZeneca @UniofOxford vaccine interim trial results —Higher efficacy w/ low dose looks real, not li…
RT @pawinpawin: ยังไม่ทันขาดคำ วัคซีนของทาง Oxford ที่เราซื้อผลก็ออกมาแล้วเหมือนกันครับ
RT @pawinpawin: ยังไม่ทันขาดคำ วัคซีนของทาง Oxford ที่เราซื้อผลก็ออกมาแล้วเหมือนกันครับ https://t.co/m4OAlExc0X
RT @CathGreenLab: Our paper with the interim results of the efficacy study for the oxford/az vaccine is out. Hurrah. https://t.co/v8ocsGA1J…
RT @TheLancet: NEW—First full results from interim analysis confirm that the Oxford #COVID19 vaccine is safe and efficacious against sympto…
RT @TheLancet: NEW—First full results from interim analysis confirm that the Oxford #COVID19 vaccine is safe and efficacious against sympto…
RT @pawinpawin: ยังไม่ทันขาดคำ วัคซีนของทาง Oxford ที่เราซื้อผลก็ออกมาแล้วเหมือนกันครับ
RT @ajpollard1: Dedicated to our friends and colleagues who have lost their lives during the pandemic https://t.co/Y70OyvbwOK
RT @vass_vassiliou: The Oxford @AstraZeneca vaccine study out @lancet! https://t.co/6xVBEKRqNT DEFINITELY WORTH A READ! The data are out,…
RT @covid19indiaorg: 2 important vaccine related readings for those who like a deep dive: 1. Early Phase 3 results of Oxford vaccine publi…
RT @pawinpawin: ยังไม่ทันขาดคำ วัคซีนของทาง Oxford ที่เราซื้อผลก็ออกมาแล้วเหมือนกันครับ
RT @VaccineWatch: AstraZenecaの新型コロナワクチンの臨床試験における有効性データがLancetに掲載されました。学術誌に有効性データが掲載されるのはこれが最初だと思います。投与量の混乱がありましたが、有効性は間違い無くあります。
Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK https://t.co/HmQDS9JGnE
RT @pawinpawin: ยังไม่ทันขาดคำ วัคซีนของทาง Oxford ที่เราซื้อผลก็ออกมาแล้วเหมือนกันครับ
RT @Emrah_Altindis: Lancet dergisine Oxford asisi faz III calismalarinin ilk sonuclari yayinlandi. Faz III ilk sonuclari bilimsel metodla a…
RT @bengibaser: 📌Lancet dergisinde Oxford aşısı Faz III çalışmalarının ilk sonuçları yayınlandı. Aşının ilk dozu dusuk, ikinci dozu yüksek…
RT @pawinpawin: ยังไม่ทันขาดคำ วัคซีนของทาง Oxford ที่เราซื้อผลก็ออกมาแล้วเหมือนกันครับ
RT @prieto_alhambra: Informe complet i 'peer reviewed' d'eficàcia i seguretat de l'anomenada "vacuna d'Oxford" (ChadOx1), ja disponibles a…
RT @pawinpawin: ยังไม่ทันขาดคำ วัคซีนของทาง Oxford ที่เราซื้อผลก็ออกมาแล้วเหมือนกันครับ
RT @CathGreenLab: Our paper with the interim results of the efficacy study for the oxford/az vaccine is out. Hurrah. https://t.co/v8ocsGA1J…
RT @pawinpawin: ยังไม่ทันขาดคำ วัคซีนของทาง Oxford ที่เราซื้อผลก็ออกมาแล้วเหมือนกันครับ
RT @pawinpawin: ยังไม่ทันขาดคำ วัคซีนของทาง Oxford ที่เราซื้อผลก็ออกมาแล้วเหมือนกันครับ
RT @EricTopol: Just out @TheLancet: @AstraZeneca @UniofOxford vaccine interim trial results —Higher efficacy w/ low dose looks real, not li…
RT @gary_lyman: Total of 5 neoplasms including benign ones in the entire study. Absolutely no useful information about role of vaccine in p…
RT @MaxCRoser: @AstraZeneca @SJVanders The paper on the Oxford vaccine is now published in The Lancet (open access) https://t.co/1WscyNi1Q8…
Total of 5 neoplasms including benign ones in the entire study. Absolutely no useful information about role of vaccine in patients with cancer and on cancer treatments. Much more needs to be done @NicoleKuderer @AstraZeneca @OxfordVacGroup @ADesaiMD
RT @EsteeTorok: More exciting news! Results just published from the @OxfordVacGroup @AstraZeneca #COVID19 #vaccine trial in the @lancet Goo…
isteyenler tam metne şuradan ulaşabilir https://t.co/okXA5fuVuW
RT @CathGreenLab: Our paper with the interim results of the efficacy study for the oxford/az vaccine is out. Hurrah. https://t.co/v8ocsGA1J…
RT @GiacomoGorini: Ecco qua, i dati di efficacia fase III del vaccino Oxford-AZ pubblicati proprio adesso sul Lancet! Ora tutta la comunità…
RT @pawinpawin: ยังไม่ทันขาดคำ วัคซีนของทาง Oxford ที่เราซื้อผลก็ออกมาแล้วเหมือนกันครับ
RT @Emrah_Altindis: Lancet dergisine Oxford asisi faz III calismalarinin ilk sonuclari yayinlandi. Faz III ilk sonuclari bilimsel metodla a…
RT @GiacomoGorini: Ecco qua, i dati di efficacia fase III del vaccino Oxford-AZ pubblicati proprio adesso sul Lancet! Ora tutta la comunità…
RT @Fraslin: Innocuité et efficacité du vaccin ChAdOx1 nCoV-19 (AZD1222) Oxford/AstraZeneca contre le SRAS-CoV-2: une analyse intermédiaire…
RT @pawinpawin: ยังไม่ทันขาดคำ วัคซีนของทาง Oxford ที่เราซื้อผลก็ออกมาแล้วเหมือนกันครับ
RT @Tony_Calles: Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised co…
RT @GiacomoGorini: Ecco qua, i dati di efficacia fase III del vaccino Oxford-AZ pubblicati proprio adesso sul Lancet! Ora tutta la comunità…
RT @joserrapa: Publicación (peer-review) del ensayo de la vacuna de Oxford / Astra @TheLancet @MartinQuirosMD
RT @pawinpawin: ยังไม่ทันขาดคำ วัคซีนของทาง Oxford ที่เราซื้อผลก็ออกมาแล้วเหมือนกันครับ
RT @AmbrizMau: La vacuna ChAdOx1 nCoV-19 tiene un perfil de seguridad aceptable y se ha encontrado que es eficaz para prevenir la COVID-19…
RT @bengibaser: 📌Lancet dergisinde Oxford aşısı Faz III çalışmalarının ilk sonuçları yayınlandı. Aşının ilk dozu dusuk, ikinci dozu yüksek…
RT @TheLancet: NEW—First full results from interim analysis confirm that the Oxford #COVID19 vaccine is safe and efficacious against sympto…
RT @bengibaser: 📌Lancet dergisinde Oxford aşısı Faz III çalışmalarının ilk sonuçları yayınlandı. Aşının ilk dozu dusuk, ikinci dozu yüksek…
RT @CaKizil: Oxford aşısının analizi @TheLancet dergisinde yayımlandı. Çalışma, aşının güvenli ve etkili olduğunu belirtiyor. Oldukça güzel…
RT @bengibaser: 📌Lancet dergisinde Oxford aşısı Faz III çalışmalarının ilk sonuçları yayınlandı. Aşının ilk dozu dusuk, ikinci dozu yüksek…
RT @gary_lyman: <0.1% were patients with cancer - we do NOT know efficacy of this vaccine in patients with malignant disease and several ot…
RT @TheLancet: NEW—First full results from interim analysis confirm that the Oxford #COVID19 vaccine is safe and efficacious against sympto…
RT @bengibaser: 📌Lancet dergisinde Oxford aşısı Faz III çalışmalarının ilk sonuçları yayınlandı. Aşının ilk dozu dusuk, ikinci dozu yüksek…